Utilization of whole genome sequencing for resolution of discrepant <i>Mycobacterium tuberculosis</i> drug susceptibility results: A case report.

Realegeno, Susan; Adeyiga, Oladunni; Winston, Drew J; Beaird, Omer E; Garner, Omai B; Yang, Shangxin

Utilization of whole genome sequencing for resolution of discrepant Mycobacterium tuberculosis drug susceptibility results: A case report.

Realegeno, Susan; Adeyiga, Oladunni; Winston, Drew J; Beaird, Omer E; Garner, Omai B; Yang, Shangxin.

Afiliación

Realegeno S; UCLA Clinical Microbiology Laboratory, Department of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Adeyiga O; Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Winston DJ; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Beaird OE; Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Garner OB; UCLA Clinical Microbiology Laboratory, Department of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Yang S; UCLA Clinical Microbiology Laboratory, Department of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, USA.

IDCases ; 26: e01308, 2021.

Article en En | MEDLINE | ID: mdl-34745885

Palabras clave

DST; Drug resistance prediction; Mycobacterium tuberculosis; Whole genome sequencing

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis Tipo de estudio: Prognostic_studies Idioma: En Revista: IDCases Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google